Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of ActivSightTM Laser Speckle Imaging in Visualization of Tissue Perfusion and Vasculature in Human

NCT04633512 is registered in ClinicalTrials.gov with Activ Surgical as lead sponsor.

NCT NCT04633512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of ActivSightTM Laser Speckle Imaging in Visualization of Tissue Perfusion and Vasculature in Human
Lead sponsor
Activ Surgical
Phase
Not applicable
Overall status
Unknown status
Start date
November 17, 2020
Completion date
January 31, 2025
Enrollment
67 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute cholecystitis, colorectal cancer, diverticulitis, colonic, inflammatory bowel diseases, obesity, morbid